Cerebral Cavernous Malformations: Review of the Genetic and Protein-Protein interactions Resulting in Disease Pathogenesis

被引:24
作者
Baranoski, Jacob F. [1 ]
Kalani, M. Yashar S. [1 ]
Przybylowski, Colin J. [1 ]
Zabramski, Joseph M. [1 ]
机构
[1] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ USA
关键词
cavernous malformation; CCM; CCM1; CCM2; CCM3; KRIT1; PDCD10;
D O I
10.3389/fsurg.2016.00060
中图分类号
R61 [外科手术学];
学科分类号
摘要
Mutations in the genes KRIT1, CCM2, and PDCD10 are known to result in the formation of cerebral cavernous malformations (CCMs). CCMs are intracranial lesions composed of aberrantly enlarged "cavernous" endothelial channels that can result in cerebral hemorrhage, seizures, and neurologic deficits. Although these genes have been known to be associated with CCMs since the 1990s, numerous discoveries have been made that better elucidate how they and their subsequent protein products are involved in CCM pathogenesis. Since our last review of the molecular genetics of CCM pathogenesis in 2012, breakthroughs include a more thorough understanding of the protein structures of the gene products, involvement with integrin proteins, and MEKK3 signaling pathways, and the importance of CCM2-PDCD10 interactions. In this review, we highlight the advances that further our understanding of the "gene to protein to disease" relationships of CCMs.
引用
收藏
页数:6
相关论文
共 49 条
[1]   Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations [J].
Bergametti, F ;
Denier, C ;
Labauge, P ;
Arnoult, M ;
Boetto, S ;
Clanet, M ;
Coubes, P ;
Echenne, B ;
Ibrahim, R ;
Irthum, B ;
Jacquet, G ;
Lonjon, M ;
Moreau, JJ ;
Neau, JP ;
Parker, F ;
Tremoulet, M ;
Tournier-Lasserve, E .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (01) :42-51
[2]   Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype [J].
Borikova, Asya L. ;
Dibble, Christopher F. ;
Sciaky, Noah ;
Welch, Christopher M. ;
Abell, Amy N. ;
Bencharit, Sompop ;
Johnson, Gary L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (16) :11760-11764
[3]   Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1α [J].
Bouvard, D ;
Vignoud, L ;
Dupé-Manet, S ;
Abed, N ;
Fournier, HN ;
Vincent-Monegat, C ;
Retta, SF ;
Fässler, R ;
Block, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) :6567-6574
[4]   Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition [J].
Bravi, Luca ;
Malinverno, Matteo ;
Pisati, Federica ;
Rudini, Noemi ;
Cuttano, Roberto ;
Pallini, Roberto ;
Martini, Maurizio ;
Larocca, Luigi Maria ;
Locatelli, Marco ;
Levi, Vincenzo ;
Bertani, Giulio Andrea ;
Dejana, Elisabetta ;
Lampugnani, Maria Grazia .
STROKE, 2016, 47 (03) :886-890
[5]   Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice [J].
Bravi, Luca ;
Rudini, Noemi ;
Cuttano, Roberto ;
Giampietro, Costanza ;
Maddaluno, Luigi ;
Ferrarini, Luca ;
Adams, Ralf H. ;
Corada, Monica ;
Boulday, Gwenola ;
Tournier-Lasserve, Elizabeth ;
Dejana, Elisabetta ;
Lampugnani, Maria Grazia .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (27) :8421-8426
[6]   Cerebral cavernous malformations: from genes to proteins to disease Clinical article [J].
Cavalcanti, Daniel D. ;
Kalani, M. Yashar S. ;
Martirosyan, Nikolay L. ;
Eales, Justin ;
Spetzler, Robert F. ;
Preul, Mark C. .
JOURNAL OF NEUROSURGERY, 2012, 116 (01) :122-132
[7]   Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1 [J].
Choquet, Helene ;
Trapani, Eliana ;
Goitre, Luca ;
Trabalzini, Lorenza ;
Akers, Amy ;
Fontanella, Marco ;
Hart, Blaine L. ;
Morrison, Leslie A. ;
Pawlikowska, Ludmila ;
Kim, Helen ;
Retta, Saverio Francesco .
FREE RADICAL BIOLOGY AND MEDICINE, 2016, 92 :100-109
[8]   Multilocus linkage identifies two new loci for a Mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27 [J].
Craig, HD ;
Günel, M ;
Cepeda, O ;
Johnson, EW ;
Ptacek, L ;
Steinberg, GK ;
Ogilvy, CS ;
Berg, MJ ;
Crawford, SC ;
Scott, RM ;
Steichen-Gersdorf, E ;
Sabroe, R ;
Kennedy, CTC ;
Mettler, G ;
Beis, MJ ;
Fryer, A ;
Awad, IA ;
Lifton, RP .
HUMAN MOLECULAR GENETICS, 1998, 7 (12) :1851-1858
[9]   Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells [J].
Crose, Lisa E. S. ;
Hilder, Thomas L. ;
Sciaky, Noah ;
Johnson, Gary L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (20) :13301-13305
[10]   The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3 [J].
Cullere, Xavier ;
Plovie, Eva ;
Bennett, Paul M. ;
MacRae, Calum A. ;
Mayadas, Tanya N. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (46) :14284-14289